NASDAQ:OMER

Omeros Stock Predictions

Healthcare > Biotechnology

Buy OMER

*Your capital is at risk

$10.16

-0.1000 (-0.97%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

OMER Prediction Chart

OMER Predictions History

Latest community submissions for OMER.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JuanC Villegas Pro	Apr 11, 2017	$17.17 +3.87%	$16.53	X	96.10%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OMER with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT OMEROS CORPORATION

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell tr...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by